Eastwood Bio-Medical Canada 

C$0.65
3
+C$0+0% 今天

統計

當日最高
0.65
當日最低
0.65
52週最高
1.15
52週最低
0.28
成交量
1,000
平均成交量
2,149
市值
52.35M
市盈率
-
股息收益率
-
股息
-

收益

29Jun預期
Q3 2020
Q4 2020
Q1 2021
Q2 2021
Q2 2021
Q1 2022
Q1 2022
-0
-0
-0
-0
預期每股收益
N/A
實際每股收益
-0.0003

人們還關注

此列表基於在 Stock Events 上關注 EBM.V 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

關於

Eastwood Bio-Medical Canada Inc. markets and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. It distributes Eleotin that provide natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. The company's licensed products include Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for development and maintenance of bones, teeth, and good health; Eleotin G2000 for cardiovascular health; Eleotin H55 for sedative and tension relief; and Eleotin Zn330 for tissue formation and metabolism. Its products also include Eleotin Bentley to promote healthy glucose levels; and Eleotin LBM for hypertension relief. The company was incorporated in 2010 and is based in Richmond, Canada. Eastwood Bio-Medical Canada Inc. operates as a subsidiary of Eastwood Bio-Medical Research Inc.
Show more...
首席執行官
Dr. Youngsoo Kim
國家
CA
ISIN
CA27783W1059

上市公司